Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

February 01, 2011 (Vol. 31, No. 3)

GEN's 30th Anniversary: mAb Therapeutics

  • Monoclonal antibody products form one of the main pillars supporting R&D efforts as well as the very structure of the global biotechnology industry. Market research company Visiongain has reported that the therapeutic monoclonal antibody market alone (not including diagnostics) led to total revenues of over $35 billion in 2009. ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.